v3.26.1
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENT (Tables)
12 Months Ended
Dec. 31, 2025
Notes and other explanatory information [abstract]  
Schedule of financial instruments
                   
        Asset/(Liability) at     Asset/(Liability) at  
Derivatives Contracts   Current/Non-Current   December 31, 2025     December 31, 2024  
   Swap - Aura Almas (Itaú Bank)   Non-current     4,418       (15,164 )
   Swap  - Apoena Mines (ABC Bank)   Current     (2,753 )     (3,872 )
   Gold Derivatives   Current / Non-current     (401,944 )     (120,454 )
Total         (400,279 )     (139,490 )
Schedule of Classification of financial instruments
                                                   
        December 31, 2025     December 31, 2024  
    Note   Measured at amortized cost     Fair value through profit & loss     Fair value through OCI     Measured at amortized cost     Fair value through profit & loss     Fair value through OCI  
Assets                                                    
Current                                                    
Cash and cash equivalents   6     286,056       -       -       270,189       -       -  
Accounts receivable   7     17,478       2,321       -       2,354       13,480       -  
Derivative Financial Instrument   27     -       -       4,418       -       -       -  
Non-current                                 -       -       -  
Other receivables and assets   10     -       -       9,691       -       -       3,454  
Assets         303,534       2,321       14,109       272,543       13,480       3,454  
                                                     
Liabilities                                                    
Current                                                    
Trade and other payables   12     189,614       -       -       98,067       -       -  
Derivative Financial Instrument   26     -       139,354       -       -       19,302       -  
Loan and debentures   13     92,497       7,051       -       78,115       3,892       -  
Liability measured at fair value   14     -       1,012       -       -       3,362       -  
Other liabilities   18     18,933               -       14,190       -       -  
Non-current                                                    
Derivative Financial Instrument   25     -       265,343       -       -       105,024       15,164  
Loan and debentures   13     132,238       179,382       -       202,474       158,623       -  
Liability measured at fair value   14     -       25,822       -       -       14,387       -  
Deferred consideration (NSR)   5(b)     -       23,643       -       -               -  
Other provisions (CVR)   17     -       11,982       -       -               -  
Other liabilities   18     6,473       -       -       11,032       -       -  
 Total         439,755       653,589       -       403,878       304,590       15,164  
Schedule of swap agreements
                       
            Asset/(Liability) at     Asset/(Liability) at  
Derivatives Contracts   Commodity/ index   Current/Non-Current   December 31, 2025     December 31, 2024  
Swap - Aura Almas (Itaú Bank) (a)   CDI   Current     4,418       (15,164 )
Swap  - Apoena Mines (ABC Bank)   CDI   Current     (2,753 )     (3,872 )
Total             1,665       (19,036 )

 

(a) The swap agreements from the Company’s subsidiary, Almas, was designated as a hedge accounting.

Schedule of financial assets and liabilities measured at fair value on a recurring basis
                                   
                                     
        December 31, 2025     December 31, 2024  
    Level   Fair value through profit & loss     Fair value through OCI     Fair value through profit & loss     Fair value through OCI  
Assets                                    
Accounts receivable   2     2,321       -       13,213       -  
Other receivables and assets   1     -       9,691       -       2,168  
Derivative Financial Instrument   2     -       4,418       -       -  
Total         2,321       14,109       13,213       2,168  
                                     
Liabilities                                    
Debentures (a)   2     186,433       -       162,515       -  
Liability measured at fair value   3     26,834       -       17,749       -  
Derivative Financial Instrument   2     404,697       -       124,326       15,164  
Deferred consideration (NSR)   3     23,643       -       -       -  
Other provisions (CVR)   3     11,982       -       -       -  
 Total         653,589       -       304,590       15,164  

 

(a) As of December 31, 2025, the debenture was trading in the market at approximately 101% of its yield curve value, which management considers to be a reasonable approximation of its carrying amount.
Schedule of inputs of fair value
               
Description Fair value at Unobservable inputs Inputs Relationship of unobservable inputs to fair value
2025 2024     2025 2024    
Liability measured at fair value (NSR agreement)) 26,834 17,749   Expected production of gold ounces 719,512 747,704   If expected production of gold ounces were 10% higher or lower, the fair value would increase/decrease by $219.
Contingent Value Rights (CVRs) 11,982 -   Commercial Production (a) -   (a)
Contingent consideration (NSR) 23,643 -   Expected production of gold ounces 315,481 -   If expected production of gold ounces were 10% higher or lower, the fair value would increase/decrease by $192.

 

(a) The Company assessed the probability of achieving commercial production, which is defined on Note 5, over various time horizons, primarily within a 0 to 20-year range, while also recognizing a residual probability of timelines extending beyond 20 years. If expected commercial production probability varies by 10% on the lower and higher ends of these time horizons, the fair value would increase or decrease by $940.
Schedule of Liability measured at fair value
       
Input   2025   2024
WACC   11.50%   11.80%
Credit-risk   2.70%   3.10%
Expected volatility   15.20%   15.70%